Here we report our ongoing investigation of the cardiovascular effects of acetaminophen, with emphasis on oxidation-induced canine myocardial dysfunction. The objective of the current study was to investigate whether acetaminophen could attenuate exogenous H2O2-mediated myocardial dysfunction in vivo. Respiratory, metabolic, and hemodynamic indices such as left ventricular function (LVDP and ±dP/dtmax), and percent ectopy were measured in anesthetized, open-chest dogs during intravenous administration of 0.88 mM, 2.2 mM, 6.6 mM H2O2. Following 6.6 mM H2O2, tissue from the left ventricle was harvested for electron microscopy. Left ventricular function did not vary significantly between vehicle and acetaminophen groups under baseline conditions. Acetaminophen-treated dogs regained a significantly greater fraction of baseline function after high concentrations of H2O2 than vehicle-treated dogs. Moreover, the incidence of H2O2-induced ventricular arrhythmias was significantly reduced in the acetaminophen-treated group. Percent ectopy following 6.6 mM concentrations of H2O2 was 1 ± 0.3 vs. 0.3 ± 0.1 (P < 0.05) for vehicle- and acetaminophen-treated dogs, respectively. Additionally, electron micrograph images of left ventricular tissue confirmed preservation of tissue ultrastructure in acetaminophen-treated hearts when compared to vehicle. We conclude that, in the canine myocardium, acetaminophen is both functionally cardioprotective and antiarrhythmic against H2O2-induced oxidative injury.
Get full access to this article
View all access options for this article.
References
1.
Autret E, Reboul-Marty J, Henry-Launois B, Laborde C, Courcier S, Goehrs JM, Languillat G, Launois R. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. Eur J Clin Pharmacol51:367–371, 1997.
2.
Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A99:13926–13931, 2002.
3.
Pelissier T, Alloui A, Paeile C, Eschalier A. Evidence of a central antinociceptive effect of paracetamol involving spinal 5HT3 receptors. Neuroreport6:1546–1548, 1995.
4.
Zweier JL TM. The role of oxidants and free radicals in reperfusion injury. Cardio Res70:181–190, 2006.
5.
Irani K XY, Zweier JL, Sollott SJ, Der CJ, et al. Mitogenic signaling mediated by oxidants in ras-transformed fibroblast. Science275:1649–1652, 1997.
Jamaluddin M, Wang S, Boldogh I, Tian B, Brasier AR. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell Signal19:1419–1433, 2007.
8.
Passos JF, Von Zglinicki T. Oxygen free radicals in cell senescence: are they signal transducers? Free Radic Res40:1277–1283, 2006.
9.
Hadzimichalis NM, Baliga SS, Golfetti R, Jaques KM, Firestein BL, Merrill GF. Acetaminophen-mediated cardioprotection via inhibition of the mitochondrial permeability transition pore-induced apoptotic pathway. Am J Physiol293:H3348–3355, 2007.
10.
Merrill GF. Acetaminophen and low-flow myocardial ischemia: efficacy and antioxidant mechanisms. Am J Physiol282:H1341–1349, 2002.
11.
Rork TH, Van Dyke K, Spiler NM, Merrill GF. Acetaminophen in the hypoxic and reoxygenated guinea pig myocardium. Exp Biol Med (Maywood, NJ)229:1154–1161, 2004.
12.
Van Dyke K, Ghareeb E, Van Dyke M, Van Thiel DH. Ultrasensitive peroxynitrite-based luminescence with L-012 as a screening system for antioxidative/antinitrating substances, e.g. Tylenol (acetaminophen), 4-OH tempol, quercetin and carboxy-PTIO. Luminescence22: 267–274, 2007.
13.
Biondi R XY, Rossi R, Paolocci N, Ambrosio G, Zweier JL. Detection of hydroxyl radicals by D-phenylalanine hydroxylation: a specific radical generation in biological systems. Anal Biochem290:138–145, 2001.
14.
Horackova M, Ponka P, Byczko Z. The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H(2)O(2) injury in adult cardiomyocytes. Cardiovasc Res47:529–536, 2000.
15.
Goldhaber JI, Ji S, Lamp ST, Weiss JN. Effects of exogenous free radicals on electromechanical function and metabolism in isolated rabbit and guinea pig ventricle. Implications for ischemia and reperfusion injury. J Clin Invest83:1800–1809, 1989.
16.
Josephson RA, Silverman HS, Lakatta EG, Stern MD, Zweier JL. Study of the mechanisms of hydrogen peroxide and hydroxyl free radical-induced cellular injury and calcium overload in cardiac myocytes. J Biol Chem266:2354–2361, 1991.
17.
Golfetti R, Rork T, Merrill G. Chronically administered acetaminophen and the ischemia/reperfused myocardium. Exp Biol Med (Maywood, NJ)228:674–682, 2003.
18.
Golfetti R, VanDyke K, Rork T, Spiler N, Merrill G. Acetaminophen in the post-ischemia reperfused myocardium. Exp Biol Med (Maywood, NJ)227:1031–1037, 2002.
19.
Merrill G, McConnell P, Vandyke K, Powell S. Coronary and myocardial effects of acetaminophen: protection during ischemia-reperfusion. Am J Physiol280:H2631–2638, 2001.
20.
Merrill GF, Goldberg E. Antioxidant properties of acetaminophen and cardioprotection. Basic Res Cardiol96:423–430, 2001.
21.
Rork TH, Hadzimichalis NM, Kappil MA, Merrill GF. Acetaminophen attenuates peroxynitrite-activated matrix metalloproteinase-2-mediated troponin I cleavage in the isolated guinea pig myocardium. J Mol Cell Cardiol40:553–561, 2006.
22.
Merrill GF, Merrill JH, Golfetti R, Jaques KM, Hadzimichalis NS, Baliga SS, Rork TH. Antiarrhythmic properties of acetaminophen in the dog. Exp Biol Med (Maywood, NJ)232:1245–1252, 2007.
23.
Merrill GF, Rork TH, Spiler NM, Golfetti R. Acetaminophen and myocardial infarction in dogs. Am J Physiol287:H1913–1920, 2004.
24.
Lucchesi BR, Hardman HF. The influence of dichloroiso-proterenol (DCI) and related compounds upon ouabain and acetylstrophanthidin induced cardiac arrhythmias. J Pharmacol Exp Ther132:372–381, 1961.
25.
Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia infarction, and reperfusion. Cardiovasc Res22:447–455, 1988.
26.
Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev87:245–313, 2007.
27.
Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res61:461–470, 2004.
28.
Goldhaber JI, Weiss JN. Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension20:118–127, 1992.
29.
Okrasa K, Kazlauskas RJ. Manganese-substituted carbonic anhydrase as a new peroxidase. Chemistry (Weinheim an der Bergstrasse, Germany)12:1587–1596, 2006.
30.
Goldhaber JI. Free radicals enhance Na+/Ca2+ exchange in ventricular myocytes. Am J Physiol271:H823–833, 1996.
31.
Wei S, Rothstein EC, Fliegel L, Dell’Italia LJ, Lucchesi PA. Differential MAP kinase activation and Na(+)/H(+) exchanger phosphorylation by H(2)O(2) in rat cardiac myocytes. Am J Physiol Cell Physiol281:C1542–1550, 2001.
32.
Sabri A, Byron KL, Samarel AM, Bell J, Lucchesi PA. Hydrogen peroxide activates mitogen-activated protein kinases and Na+ -H+ exchange in neonatal rat cardiac myocytes. Circ Res82:1053–1062, 1998.
33.
Suzuki YJ, Cleemann L, Abernethy DR, Morad M. Glutathione is a cofactor for H2O2-mediated stimulation of Ca2+-induced Ca2+ release in cardiac myocytes. Free Radic Biol Med24:318–325, 1998.
34.
Manunta P, Ferrandi M. Cardiac glycosides and cardiomyopathy. Hypertension47:343–344, 2006.
35.
Shao Q, Matsubara T, Bhatt SK, Dhalla NS. Inhibition of cardiac sarcolemma Na(+)-K+ ATPase by oxyradical generating systems. Mol Cell Biochem147:139–144, 1995.
36.
Tokube K, Kiyosue T, Arita M. Openings of cardiac KATP channel by oxygen free radicals produced by xanthine oxidase reaction. Am J Physiol271:H478–489, 1996.
37.
Gumina RJ, Terzic A, Gross GJ. Do NHE inhibition and ischemic preconditioning convey cardioprotection through a common mechanism? Basic Res Cardiol96:318–324, 2001.
38.
Doggrell SA, Hancox JC. Is timing everything? Therapeutic potential of modulators of cardiac Na(+) transporters. Expert Opin Investig Drugs12:1123–1142, 2003.
39.
Masereel B, Pochet L, Laeckmann D. An overview of inhibitors of Na(+)/H(+) exchanger. Eur J Med Chem38:547–554, 2003.
40.
Fukuda K, Davies SS, Nakajima T, Ong BH, Kupershmidt S, Fessel J, Amarnath V, Anderson ME, Boyden PA, Viswanathan PC, Roberts LJ 2nd, Balser JR. Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ Res97:1262–1269, 2005.
Prescott LF. Paracetamol: past, present, and future. Am J Thera7:143–147, 2000.
47.
Hearse DJ, Humphrey SM, Nayler WG, Slade A, Border D. Ultrastructural damage associated with reoxygenation of the anoxic myocardium. J Mol Cell Cardiol7:315–324, 1975.
48.
Hegstad AC, Ytrehus K, Lindal S, Myklebust R, Jorgensen L. The initial phase of myocardial reperfusion is not associated with aggravation of ischemic-induced ultrastructural alterations in isolated rat hearts exposed to prolonged global ischemia. Ultrastruct Pathol23: 93–105, 1999.
49.
Bogoyevitch MA, Ng DC, Court NW, Draper KA, Dhillon A, Abas L. Intact mitochondrial electron transport function is essential for signalling by hydrogen peroxide in cardiac myocytes. J Mol Cell Cardiol32:1469–1480, 2000.
50.
Chen QM, Tu VC, Wu Y, Bahl JJ. Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes. Arch Biochem Biophys373:242–248, 2000.
51.
Loh SH, Tsai CS, Tsai Y, Chen WH, Hong GJ, Wei J, Cheng TH, Lin CI. Hydrogen peroxide-induced intracellular acidosis and electromechanical inhibition in the diseased human ventricular myocardium. Eur J Pharmacol443:169–177, 2002.
